These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prevalence and significance of serum 14-3-3η in juvenile idiopathic arthritis. Reyhan I, Zhukov OS, Lagier RJ, Bridgforth RF, Williams GJ, Popov JM, Naides SJ, Reiff A. Pediatr Rheumatol Online J; 2021 Feb 16; 19(1):14. PubMed ID: 33593401 [Abstract] [Full Text] [Related]
8. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL. J Rheumatol; 2004 Sep 16; 31(9):1829-33. PubMed ID: 15338508 [Abstract] [Full Text] [Related]
9. Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population. Kwok JS, Hui KH, Lee TL, Wong W, Lau YL, Wong RW, Kim DL, Jones BM. Scand J Rheumatol; 2005 Sep 16; 34(5):359-66. PubMed ID: 16234183 [Abstract] [Full Text] [Related]
10. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis. Brunner J, Sitzmann FC. Clin Exp Rheumatol; 2006 Sep 16; 24(4):449-51. PubMed ID: 16956438 [Abstract] [Full Text] [Related]
11. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis. Pang SY, Liu HY, Huang YJ, Liu YF, Dai YM, Zeng P, Zeng HS. Genet Mol Res; 2016 May 13; 15(2):. PubMed ID: 27323035 [Abstract] [Full Text] [Related]
13. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Habib HM, Mosaad YM, Youssef HM. Immunol Invest; 2008 May 13; 37(8):849-57. PubMed ID: 18991100 [Abstract] [Full Text] [Related]
14. Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial). Omar A, Abo-Elyoun I, Hussein H, Nabih M, Atwa H, Gad S, Emad Y. Joint Bone Spine; 2013 Jan 13; 80(1):38-43. PubMed ID: 22575064 [Abstract] [Full Text] [Related]
15. Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA). Berntson L, Nordal E, Fasth A, Aalto K, Herlin T, Nielsen S, Rygg M, Zak M, Rönnelid J, Nordic Study Group of Pediatric Rheumatology (NoSPeR). Pediatr Rheumatol Online J; 2014 Jan 13; 12():22. PubMed ID: 24944545 [Abstract] [Full Text] [Related]
16. [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis]. Zhang L, Ru J, Jie X, Che G, Jin X, Li X. Zhonghua Er Ke Za Zhi; 2015 Dec 13; 53(12):948-51. PubMed ID: 26887552 [Abstract] [Full Text] [Related]
17. Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Gupta R, Thabah MM, Vaidya B, Gupta S, Lodha R, Kabra SK. Indian J Pediatr; 2010 Jan 13; 77(1):41-4. PubMed ID: 20135267 [Abstract] [Full Text] [Related]
18. Race, ethnicity, and disease outcomes in juvenile idiopathic arthritis: a cross-sectional analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. Ringold S, Beukelman T, Nigrovic PA, Kimura Y, CARRA Registry Site Principal Investigators. J Rheumatol; 2013 Jun 13; 40(6):936-42. PubMed ID: 23588937 [Abstract] [Full Text] [Related]
19. Rheumatoid factors and anticyclic citrullinated peptide antibodies in pediatric rheumatology. Syed RH, Gilliam BE, Moore TL. Curr Rheumatol Rep; 2008 Apr 13; 10(2):156-63. PubMed ID: 18460272 [Abstract] [Full Text] [Related]
20. Anti-CCP antibodies in Brazilian children and adults with juvenile idiopathic arthritis. Bacos S, Bortolozzi SG, Skare TS, Spelling PF, Utiyama SR, Nisihara R. Clin Rheumatol; 2014 Jul 13; 33(7):1001-3. PubMed ID: 24651918 [Abstract] [Full Text] [Related] Page: [Next] [New Search]